AUCTORES
Globalize your Research
Research Article
*Corresponding Author: Stalin Reddy Challa, Deportment of Pharmaceutics, Jangaon Institute of Pharmaceutical Sciences, India.
Citation: Stalin Reddy Challa and Swathi Goli, Differentiation of Human Embryonic Stem Cells into Engrafting Myogenic Precursor Cells. J. Stem cell Research and Therapeutics International, DOI: 10.31579/2643-1912/002
Copyright: © 2019 Stalin Reddy Challa, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 16 March 2019 | Accepted: 09 April 2019 | Published: 11 April 2019
Keywords: muscle tissue; human embryonic stem cells; myogenic precursor; immunodeficient
Degenerative muscle diseases affect muscle tissue integrity and function. Human embryonic stem cells (hESC) are an attractive source of cells to use in regenerative therapies due to their unlimited capacity to divide and ability to specialize into a wide variety of cell types. A practical way to derive therapeutic myogenic stem cells from hESC is lacking. In this study, we demonstrate the development of two serum-free conditions to direct the differentiation of hESC towards a myogenic precursor state. Using TGFß and PI3Kinase inhibitors in combination with bFGF we showed that one week of differentiation is sufficient for hESC to specialize into PAX3+/PAX7+ myogenic precursor cells. These cells also possess the capacity to further differentiate in vitro into more specialized myogenic cells that express MYOD, Myogenin, Desmin and MYHC, and showed engraftment in vivo upon transplantation in immunodeficient mice. Ex vivo myomechanical studies of dystrophic mouse hindlimb muscle showed functional improvement one month post-transplantation. In summary, this study describes a promising system to derive engrafting muscle precursor cells solely using chemical substances in serum-free conditions and without genetic manipulation.
Muscular dystrophies are debilitating degenerative muscle diseases caused by defective muscle proteins that disrupt normal homeostasis [1,2]. During embryogenesis Pax3 and Pax7-expressing cells drive muscle formation, growth and repair [3-8]. In the postnatal period, these cells are termed satellite cells –stem cells that remain quiescent beneath the basal lamina of muscle fibers under normal conditions. Tissue damage triggers these cells to proliferate and differentiate into myoblasts, leading to the formation of multinucleated myotubes and fibers [9-12]. However, dystrophic tissue induces repeated activation of satellite cells, ultimately leading to stem cell exhaustion, limiting the ability for further restorative myogenesis. Given their role in muscle formation, growth and repair, satellite cells, or other myogenic precursors with similar characteristics, would be attractive candidates for cell-based therapies for muscular dystrophies. Successful cell therapy would require myogenic precursor cells to: i. repopulate damaged muscle, ii. contribute to the formation of muscle fibers, and iii. lead to expression of normal muscle proteins in host tissue [13]. In addition, an important therapeutic benefit would be repopulation of the muscle stem cell niche to allow for ongoing homeostasis.
Embryonic stem cells (ESC) have the capacity to expand indefinitely, while maintaining the ability to differentiate into a wide variety of cell types. As such ESC may be useful for cell transplantation therapy or tissue engineering. However, a non-genetics method to obtain hESC derivatives with muscle regenerative abilities is lacking. Promising attempts to derive human myogenic precursors from pluripotent stem cells have relied on viral–mediated MYOD-expression [14-18], serum-containing media [14,15], use of demethylating agents [15], or selective multi-step cell culture approaches and cell sorting procedures that may be difficult to implement on a large-scale [16]. The most efficient methods described to date used genetic manipulation of human ESC (hESC) to overexpress the myogenic transcription factors, PAX3 and PAX7 [19]. Importantly, the use of genetically manipulated or virally induced cells, as well as cells exposed to serum that contains non-human components, may be difficult to use in human trials due to safety concerns.
Therefore, in order to establish alternative ways of driving early myogenic specification, we leveraged previous studies describing chemical compounds that stimulate and facilitate hESC differentiation toward paraxial mesoderm, the lineage responsible for limb and limb-associated skeletal muscle development. hESC can be chemically stimulated by activation of the bone morphogenetic protein (BMP) pathway, which is a key inducer of mesoderm formation during embryogenesis [14,20-24]. Treatment with the phosphatidylinositol 3-kinase (PI3K) inhibitor, Ly294002 hydrochloride (Ly), facilitates the differentiation of hESC by reducing self-renewal ability [25,26]. Additionally, paraxial mesoderm, the lineage responsible for limb muscle development, can be formed by brief stimulation with BMP and inhibition of the TGFb/Activin pathway using the small molecule, SB431542 (SB) [27]. This compound specifically inhibits the Activin pathway without affecting BMP signaling. It has been shown that inhibition of the TGFb/Activin pathway using SB up-regulates myogenic genes during hESC differentiation in defined culture conditions [14]. Another important factor in mesoderm formation is fibroblast growth factor (FGF), which also determines myogenic fate during development and plays a role in satellite cell activation [28-31]. Therefore, it is plausible that these components could be used to drive myogenesis in hESC cultures.
Based on these observations, we hypothesized that engrafting myogenic precursors could be derived from hESC by the sequential and coordinated manipulation of the BMP, TGFß and FGF pathways. Importantly, we sought to prove that myogenic specification of hESC could be achieved without the use of allogeneic components in serum or genomic alteration. To this end, we tested whether myogenesis could be induced through embryoid body (EB) differentiation in medium containing basic fibroblast growth factor (bFGF), Ly and low levels of FGF, in combination with short exposure to BMP4 (referred to as KFLy(B)S medium). Separately, a combination of FGF and SB alone was tested for the ability to drive myogenesis (referred to as KFS medium). We determined the capacity of hESC-derived myogenic precursors to engraft in skeletal muscle upon transplantation in hindlimb muscles of SCID mice. In addition, we determined functional changes in transplanted muscle of mdx mice using ex vivo myomechanical analysis. The novel differentiation approach described in this study circumvents many of the limitations encountered in the transition of pluripotent stem cells into myogenic precursor cells, while enhancing our understanding of the mechanisms that govern stem cell differentiation and skeletal myoge
Human ESC culture and myogenic differentiation
All work with hESC was done with the approval of UCSF Stem Cell Research Oversight Committee. The H9 hESC (WA09; WiCell) were maintained on irradiated CF1 mouse embryonic fibroblasts (MEF; Millipore, Temecula, CA) in KSR medium [Knockout Dulbecco’s Modified Eagle Medium containing 20% Knockout Serum Replacement, 2mM glutamine, 0.1 mM nonessential amino acids, 0.1 mM β-mercaptoethanol (all from Invitrogen, Carlsbad, CA)] supplemented with 12.5 ng/ml recombinant human fibroblast growth factor basic (bFGF; R&D Systems, Minneapolis, MN) as previously described [32].
hESC colonies were detached after brief exposure to Collagenase IV (1 mg/ml; Sigma-Aldrich, St. Lois, MO), washed and collected by settlement. Differentiation was initiated by embryoid body (EB) formation in pre-differentiation medium KFLy(B)S: KSR medium freshly supplemented with 20 ng/ml bFGF, 10 μM Ly294,002 hydrochloride (Ly; Sigma-Aldrich), 10 μM SB431542 hydrate (SB; Sigma-Aldrich), and for the first 36 hours supplementing with recombinant human bone morphogenetic protein-4 (BMP-4) (10 ng/ml; HumanZyme, Chicago, IL), or pre-differentiation medium KFS: KSR medium freshly supplemented with 40 ng/ml bFGF and 10 μM SB. Both pre-differentiation media were supplemented one time with 10 μM Rho-associated protein kinase inhibitor (ROCKi) at the day of EB formation. SB and Ly were reconstituted in dimethylsulfoxide (DMSO) at 20 mM, and diluted to the final concentration in pre-differentiation medium. Human EBs were kept in suspension in ultra-low cluster 6-well plates (Costar, Corning, NY) and placed onto an orbital shaker (Daigger, Vernon Hills, IL) at a speed of 90 rpm. After 36 hours, medium was refreshed, which was repeated every other day until day six.
To assess the myocyte-forming potential of EB-derived myogenic precursor cells derived in KFLy(B)S and KFS (differentiation day 6) media, EBs were plated onto 12.5 μg/cm2 fibronectin (from human plasma; Sigma-Aldrich) in 0.1% gelatin-coated culture surfaces in pre-differentiation medium to stimulate cell outgrowth. After two days, medium was replaced with muscle differentiation medium [DMEM-high glucose, 10% fetal bovine serum (FBS; Hyclone, Thermo Scientific, South Logan, UT), 5% horse serum (HS; also from Hyclone) supplemented with 5 ng/ml bFGF] and cultured for an additional 4 days.
Quantitative real-time PCR
RNA was extracted from cells using the RNeasy Mini Kit including DNase treatment (Qiagen, Valencia, CA) according to the manufacturer's instruction. RNA concentration was measured using a Nanodrop ND-1000 Spectrophotometer (Nanodrop Technologies) to convert equal quantities of mRNA into cDNA using the Superscript™ III First-Strand Synthesis System (Invitrogen). Relative gene expression was determined using TaqMan Assay (Applied Biosytems) on an ABI 7300 Real-Time PCR system with the following human primer pairs (ABI): OCT4 (Hs00742896_s1); Brachyury (T) (HS00610080_m1); PAX3 (Hs00240950_m1); PAX7 (Hs00242962m1); MYOD (Hs00159528_m1); Desmin (Hs01090875_m1); Myogenin (Hs002311167_m1); MYHC (Hs00430042_m1) and GAPDH (4326317E). Cycle threshold (Ct) value for detection of gene of interest was normalized against Ct value of the housekeeping gene, human GAPDH, and relative changes were calculated according the ΔΔCt method. Results of relative fold expression were analyzed using GraphPad prism software in a two-way ANOVA with Bonferroni post-test.
Immunostaining
Immunofluorescence staining was performed on EB-outgrowths cultured in of KFLy(B)S or KFS with mouse anti-human Pax7 (undiluted), Myogenin (F5D; undiluted) and MyHC (MF20; 1:20) antibodies (all three supernatants from Developmental Studies Hybridoma Bank); mouse anti-human MyoD (5.8A; 20 μg/ml; R&D systems); or mouse anti-human Desmin (D33; 10 μg/ml; Dako, Glostrup, Denmark). Cells were fixed in 4% paraformaldehyde (PFA; EMS, Fort Washington, PA) for 15 min. and permeabilized in 0.4% Triton-X100 for 10 min. After blocking for 30 min in blocking solution [2% normal goat serum (NGS; Dako), 1% bovine serum albumin (BSA; Sigma-Aldrich), 0.1% cold fish gelatin (Sigma-Aldrich), 0.1% Triton-X100, 0.05% Tween-20 in phosphate buffered saline (PBS)], cells were subsequently incubated with the primary antibodies diluted in blocking solution for 1 hr. After washing (three times; 5 min in PBS with 0.05% Tween-20), primary antibodies were detected using Alexa Fluor® 488-labeled goat anti-mouse (1:200; Life Technologies, Grand Island, NY) for 30 min. All steps were performed at room temperature (RT). Fluorescence microscopy was performed using a Nikon Eclipse TE300 microscope and Zeiss AxioScope Imager Z.2 with Apotome (Zeiss, Inc, Thornwood, NY).
Intramuscular cell transplantation
All experiments involving animals were done with the approval of the UCSF Institutional Animal Care and Use Committee. Hindlimbs of CB17.B6-PrkdcscidLyst bg/Crl (8-12 wk-old) and C57BL/10ScSn-Dmdmdx/J (X-linked muscular dystrophy; aged 6-8 weeks) mice (Jackson Laboratories, Bar Harbor, ME) were exposed to gamma radiation (5 Gy and 18 Gy, respectively) three days before cell transplantation to inhibit muscle regeneration by host muscle cells. Mice cages were supplied with a water bottle containing an antibacterial oral suspension (200 mg sulfamethoxazole-40 mg trimethoprim/ 200 ml water) from the day of irradiation through euthanasia. For intramuscular injection, EB-derived in KFLy(B)S or KFS were trypsinized and filtered through 40 μm nylon cell strainer (Gibco) to obtain a single cell suspension. One million cells cultured in KFLy(B)S or KFS were suspended in 50 μl PBS (supplemented with 10 μM ROCKi) and injected into the tibialis anterior (TA) muscle at two sites. As control, the contra-lateral muscle was injected with 50 μl PBS with 10 μM ROCKi. TA muscles were analyzed by immunohistochemistry one month post-transplantation, as described above.
Immunohistochemistry
TA muscles were embedded in OCT, snap-frozen in liquid nitrogen and stored at -80°C. Cryosections (5 mm) were fixed in acetone (ice cold, 10 min) and blocked in blocking solution [5% NGS, 5% Normal Donkey Serum (Dako), 5% BSA, 0.1% cold fish gelatin, 0.1% Triton-X100, 0.05% Tween-20 in PBS]. Sections were incubated with rabbit anti-human Dystrophin (1:2500; Novus Biologicals, Littleton, CO), chicken anti-mouse Laminin (2 mg/ml; Abcam), mouse anti-human Desmin (10 μg/ml; D33; Dako), or mouse anti-human HLA-1 (W6/32; antigen determinant common to HLA-A, B and C; 4 mg/ml; provided by Frances Brodsky, Dept. of Biopharmaceutical Sciences, UCSF) in blocking buffer for 1 hour. Alexa488/594-conjugated goat anti-mouse IgG, Alexa594-Donkey anti-Rabbit IgG, or Alexa488-Goat anti-Chicken IgG (1:250; all from Life Technologies) were used to detect primary antibodies. Sections were then washed and dehydrated in ethanol (70%, 90%, 100%; 5 min each), air-dried, and mounted in Vectashield with DAPI (Vector, Burlingame, CA). For immunohistochemical detection, sections were additionally blocked for endogenous peroxidase (0.3% H2O2 in PBS, 20min). Primary antibody HLA-1 was detected by peroxidase labeled goat anti-mouse. Visualization was performed by a 3-amino-9-ethyl-carbazole (AEC; Sigma) substrate incubation for 4 minutes. Nuclei were counterstained with Mayer’s haematoxyline (2 min, Fluka, Buchs, Zwitserland). All steps were performed at RT. Fluorescence microscopy was performed using a Nikon Eclipse TE300 microscope and Zeiss AxioScope Imager Z.2 with Apotome (Zeiss, Inc, Thornwood, NY).
Ex vivo myomechanical analysis of transplanted EDL muscle in mdx mouse model
Ex vivo myography was performed to determine the increase in force production and to determine muscle fatigue level after cell transplantation into the extensor digitorum longus (EDL) muscle of mdx mouse. Myomechanical analysis was performed as previously described [33,34]. Force-frequency fatigue was measured by exposing muscle to a supramaximal stimulus train of 3-5 pulses (300 msec duration separated by 3 sec) at successive frequencies (30, 60, 100 and 140 Hz), with 5 minute intervals between stimulations. Low-frequency time-fatigue was measured by supramaximal tetanic muscle stimulation at low frequency (60 Hz) for duration of 300 msec, repeated every 3 seconds for a period of 10 minutes. For myo-mechanical analysis, the left and right leg variables of an animal were averaged in each group and muscle mass, cross-sectional area, and length was measured. Significant differences were present between the means of each group compared to the PBS group. Multiple t-tests were performed with the number of comparisons adjusted by Bonferroni correction. A value of p <0.05 was considered significant.
nhibition of TGFβ pathway directs myogenic commitment
To compare previously described, serum-containing methods for their capacity to induce the formation of myogenic precursors, we differentiated hESC by a selective culture approach using serum-containing (10% FBS) medium to enrich for CD73+ mesodermal stem cells followed by a second cell sort for expression of neural cell adhesion molecule (NCAM), a molecule also expressed by myogenic cells [16]. Furthermore, we differentiated hESC-EB in low serum conditions (2% HS) [35-37] and high serum conditions (10% FBS) during 2-4 weeks in culture [15]. We observed expression of PAX7 in cells derived through the selective multi-step methods (preCD73/NCAM sort) and when exposed to low and high serum conditions (Figure 1A). Addition of SB, a compound that inhibits the TGFb pathway, to cells differentiated in 10% FBS culture conditions resulted in markedly increased PAX7 levels (Figure 1A) *p<0.01. This indicated the myogenic stimulatory effect of TGFb inhibition in hESC. Next, we transiently stimulated the BMP pathway with BMP4 during EB differentiation combined with Ly and high levels of bFGF in serum-free conditions (KFLy(B)). This resulted in high levels of PAX7 expression (Figure 1A) p<0.001. This was also seen when EB were exposed solely to high concentrations of FGF (KF) (Figure 1A) p<0.001.
Myogenic differentiation in EB culture
We hypothesized that myogenic precursor cells would be more likely to engraft in host muscle, and have a greater chance of repopulating the stem cell niche, than fully differentiated myoblasts. To monitor the stages of myogenic differentiation, we cultured hESC-EB in serum-free KFLy(B)S or KFS and examined myogenic gene expression by qRT-PCR at days 2, 4, 6 and 8, relative to undifferentiated hESC (day 0). OCT4 expression was used as an indicator of residual pluripotency after initiation of hESC differentiation. In both differentiation conditions, OCT4 expression fell dramatically by day 2 and further diminished through day 6 of differentiation (Figure 2) p<0.001.
KFLy(B)S- and KFS-derived precursors differentiate into myoblasts in vitro
Directed differentiation of stem cells can be stimulated with exposure to specific extracellular matrix (ECM) components they would likely encounter in the stem cell niche [42]. This has specifically been shown for stem cell differentiation toward the myogenic lineage [43,44]. EB differentiated for 6 days in KFLy(B)S or KFS were plated in dishes coated with Matrigel, laminin or fibronectin to stimulate myogenic cell outgrowth. We observed that attachment to fibronectin-coated dishes, compared to Matrigel and laminin, more effectively promoted myogenic differentiation (data not shown). Therefore, fibronectin coating was used to evaluate the myogenic potential of EB-outgrowth cells (EB-O) during the subsequent 6 days in muscle differentiation medium.
PAX3 and PAX7 are critical factors in embryonic skeletal myogenesis and participate after birth in muscle homeostasis. They are, therefore, important indicators of a myogenic precursor stage that harbors regenerative capacity. Several methods have been published describing the myogenic differentiation of hESC, however, limitations of published methods include the use of non-human serum and genetic manipulation that may hamper therapeutic application due to safety concerns [48,49]. This study underscores that myogenesis can be achieved in hESC cultures in a short time frame when exposed to appropriate developmental cues. We have demonstrated two approaches to derive PAX3- and PAX7-expressing myogenic precursors from hESC using a novel sequence of chemical compounds that direct a myogenic cell fate. Upon transplantation, these muscle precursor cells engrafted into muscle, formed new fibers, and improved muscle strength.
In the course of this study a publication revealed the success of a chemically defined culture system in transgenic zebrafish that directs skeletal myogenesis of human induced pluripotent stem cells [50]. Therefore, the combination of pathway inhibitors and stimulators described in this study provide an effective platform to advances approaches to muscle differentiation from hESC. Among the benefits are the avoidance of the use of serum and genetic alteration to promote gene expression. Furthermore, we showed that hESC entered the myogenic program in less then one-week making this approach faster than other published methods applying hESC differentiation during 2-4 weeks. Additionally, lacking selective cell culture approaches contributed to a method that is costs effective and easy.
In mdx mice, transplantation with hESC-derived precursors derived using these methods resulted in improved mechanical force generation and decreased fatigue. Both muscles injected with KFLy(B)S and KFS-derived cells demonstrated higher maximal tension than muscle injected with PBS or EDL that was not injected with cells, indicating improved functional capacity. Interestingly, EDL from mice injected with KFLy(B)S-derived cells demonstrated greater maximal tetanic tension, compared to both EDL from mice injected with PBS and KFS-derived cells and EDL that was not injected. However, force-frequency analysis demonstrated decreased fatigue in muscle from mice injected with KFS-derived cells compared to the other groups. The mechanisms that might account for these differences are unclear, but it is intriguing that the ESC-derived precursors could alter functional capacity by affecting different muscle properties (e.g strength vs endurance). Most importantly, however, the findings of the myomechanical analysis indicate preliminary proof-of-concept for functional myogenic potential for these hESC-derived precursor cells.
We have shown that a short exposure of hESC to chemically defined media promotes differentiation of hESC into engrafting myogenic precursor cells that can contribute to the formation of new fibers in vivo and improve muscle strength as analyzed ex vivo. These techniques are less laborious than previously published methods, and the avoidance of xenobiotic agents and serum may mitigate safety concerns. Further studies to assess durability of transplanted cells and newly formed fibers, as well as their contribution to muscle homeostasis over time are warranted.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
